William B Schwartz Division of Nephrology, Tufts Medical Center, Boston, MA 02111, USA.
Lancet. 2012 Jan 14;379(9811):165-80. doi: 10.1016/S0140-6736(11)60178-5. Epub 2011 Aug 15.
Chronic kidney disease is a general term for heterogeneous disorders affecting kidney structure and function. The 2002 guidelines for definition and classification of this disease represented an important shift towards its recognition as a worldwide public health problem that should be managed in its early stages by general internists. Disease and management are classified according to stages of disease severity, which are assessed from glomerular filtration rate (GFR) and albuminuria, and clinical diagnosis (cause and pathology). Chronic kidney disease can be detected with routine laboratory tests, and some treatments can prevent development and slow disease progression, reduce complications of decreased GFR and risk of cardiovascular disease, and improve survival and quality of life. In this Seminar we discuss disease burden, recommendations for assessment and management, and future challenges. We emphasise clinical practice guidelines, clinical trials, and areas of uncertainty.
慢性肾脏病是一组影响肾脏结构和功能的异质性疾病的总称。2002 年该疾病的定义和分类指南代表了一个重要的转变,即认识到它是一个全球性的公共卫生问题,应该由普通内科医生在早期进行管理。疾病和治疗是根据疾病严重程度的分期来分类的,分期是根据肾小球滤过率(GFR)和蛋白尿来评估的,还有临床诊断(病因和病理)。慢性肾脏病可以通过常规实验室检查来检测,一些治疗方法可以预防其发生和减缓疾病进展,减少 GFR 降低和心血管疾病风险的并发症,提高生存率和生活质量。在本次研讨会上,我们讨论了疾病负担、评估和管理建议,以及未来的挑战。我们强调了临床实践指南、临床试验和不确定领域。